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ABSTRACT 
This study shows that HPLC-LALLS (high performance liquid 
chromatography with a light-scattering detector) is a convenient and 
reliable method for the characterization of standard heparin 
samples, provided that polyelectrolyte artefacts are suppressed by a 
suitable dialysis procedure. The method has been succesfully applied 
to the assessment of calibrated relations like the Mark-Houwink 
relation and the calibration curve of gel permeation chromatography. 
Furthermore, this study confirms that gel permeation chromatography 
for heparins cannot be calibrated with dextranes or 
polyethyleneglycols, but in addition to this well known fact it is 
shown that even the universal (hydrodynamic volume) calibration 
procedure does not work. Moreover, in addition to the familiar 
conclusion that heparins should be calibrated with heparins, it is 
shown that calibrated relations are valid only when the calibration 
has been made with heparin samples of the same origin (i.e. same 
tissue source, same animal source, and same purification scheme). 
INTRODUCTION 
Commercially available heparins from different manufacturers differ in 
molecular mass distribution and in chemical composition, according to animal 
source, tissue source and purification scheme (1). In this respect tissue 
source seems to be more important than animal source (2). This has drawbacks 
for the determination of average molecular masses from calibrated relations 
like the Mark-Houwink relation between intrinsic viscosity and mass average 
molecular mass % (3,4). Once established by means of well-characterized 
heparin samples, ?t is valid only for samples consisting of polymer 
Keywords: heparin, heparin fractions, molecular mass, light scattering, gel 
permeation chromatography, Mark-Houwink relation 
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molecules of the same chemical composition. That is, for heparins stemming 
from the same origin (i.e. same animal source, same tissue source and same 
purification scheme). Thus, even the calibration of a Mark-Houwink relation 
for heparins with heparins is not enough: in principle, a systematic error is 
introduced when applying the Mark-Houwink relation established for 
heparin-samples of one origin (characterized by the same tissue and animal 
sources and the same purification scheme (2)) to samples of another origin. In 
this paper we will show that there is such an error indeed. 
The same problem will arise with the assessment of other calibrated relations. 
Generally speaking, those are (usually) relations between some easily 
measurable transport property of a polymer and some not so easily accessible 
average molecular weight of this polymer. Thus, the crucial relation in gel 
permeation chromatography between top-of-peak elution volume and molecular 
mass (the so-called calibration curve), once established for known heparin 
samples of a certain origin, can only be applied to unknown samples of the 
same origin. This will also hold true for still another calibrated relation: 
that between sedimentation coefficient and Ew (3). 
Thus, the assessment of calibrated relations for heparins from a certain 
origin requires (i) a reliable method for the determination of molecular 
weight distributions of heparin samples of the same origin that will serve as 
standard samples, and (ii) a reliable method for the construction of a 
calibration curve from the molecular mass distributions of these standards. In 
this paper we will show that HPLC-LALLS (high performance gel permeation 
chromatography coupled to an absolute molecular mass detector, LALLS: low 
angle laser light scattering (5)) provides molecular mass distributions of 
standard heparin samples in a quick and reliable way. 
The application of HPLC-LALLS analysis to heparin samples has also been 
referred to by Van Dedem (6) in a comparative study on the determination of 
heparin molecular mass distributions with HPLC. Our study, however, will 
present some proviso's as to the reliability and the accuracy of the 
HPLC-LALLS method. Moreover, we will discuss the applicability of the light 
scattering method as such to aqueous solutions of a copolymeric 
polyelectrolyte like heparin. 
In addition, we will show that gel permeation chromatography of heparins using 
other polymers (like dextranes (7) or polyethyleneglycols) as standards leads 
to wrong results, even when processed by the "universal balibration" procedure 
(where the calibration curve consists of hydrodynamic polymer volume rather 
than molecular mass plotted against elution volume (8)). 
MATERIALS AND METHODS 
Heparins: Two heparins (sodium salt, 164 E/mg) of the same animal and tissue 
source (porcine intestinal mucosa), and the same purification scheme were 
obtained as gifts (we regret that we cannot provide batch numbers), with no 
more specifications than those regarding expected molecular weight (range), 
and origin and purification scheme. A low molecular mass product was a gift of 
Kabi Vitrum, Amsterdam, the Netherlands. The other product had a broad 
molecular mass distribution and was a gift of Diosynth, Oss, the Netherlands. 
The latter product (10 g) was fractionated over a Biogel column (PZOO, Biorad, 
Richmond, CA, USA) as described previously (9). Six fractions with decreasing 
molecular masses were obtained. The yields, after exhaustive dialysis against 
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water and lyophilization, were 0.2 g, 1.7 g, 2.0 g, 2.2 g, 1.9 g and 1.5 g for 
fractions #l t0 86, respectively. 
HPLC-LALLS analysis: Our HPLC-LALLS equipment was assembled from a pump 
(Waters, model 6000 A), an injector (Waters U6K), one or two HPLC columns (see 
below), a LALLS molecular mass detector (Chromatix KMX-6) and a concentration 
detector (Waters differential refractometer, R 401). Columns used were: 
Toyosoda/TSK PW 3000 (300 x 7.5 mm; molecular mass exclusion limits for 
polyethyleneglycol (PEG) in water: 100 and 10000; between these limits the 
column is not linear, however), Toyosoda/TSK PW 4000 (300 x 7.5 mm; 
(non-linear) molecular mass range (PEG): lOOO-100,000) and Toyosoda SW 3000 
(600 x 7.5 mm; linear molecular mass range (PEG) lO,OOO-100,000). 
Elution was performed at room temperature at a flow rate of 1.0 ml/min using 
0.1 M NaAc buffer, adjusted with acetic acid to pH 6.0, as the mobile phase. 
Heparin solutions (50 microliter) with a concentration of 1 % (w/v) were 
injected. 
Heparin samples used were dialysed against the elution buffer solution in 
order to eliminate (10) Donnan-type artefacts in the molecular mass 
determination by light scattering. To this end also, the refractive index 
increments (dn/dc) of the samples (at the LALLS wavelength > = 633 nm and at 
T 25 'C) were measured against the dialysis equilibrium liquid as the blank 
(10) in a Brice-Phoenix differential refractometer. We found dn/dc values 
ranging from 0.110+0.002 ml/g (for the lowest molecular mass sample) to 
0.118&0.002 ml/g (for the high molecular mass sample). (We have no indications 
that during this dialysis procedure heparin was lost: all losses must have 
occurred during the fractionation procedure end the subsequent exhaustive 
dialysis described above (see "Heparins").) 
Calculation procedures for molecular mass distributions and averages are 
described below (results section). The reproducibility of the top-of-peak 
elution volumes was within 1% on each set of columns, and that of molecular 
mass averages calculated from HPLC-LALLS or from HPLC only (based on previous 
LALLS calibration) was within 8% or 5%, respectively. The LALLS signal becomes 
vanishingly small for molecular masses lower than about 6000; hence the KABI 
sample was at the verge of non-detectability. 
Membrane osmometry: The fi values derived from HPLC-LALLS measurements were 
checked against osmometri: measurements (11). A Stabin (type M2) membrane 
osmometer equipped with a dialysis tubing membrane (063-F-09, Tamson, 
Zoetermeer, the Netherlands) was used. Measurements were carried out for 
series consisking of at least 3 dilutions (the highest one being 10 mg/ml), at 
25 f 0.002 C, in a 0.1 M NaAc adjusted with acetic acid to pH 6.0 as the 
solvent. Some NaN 
solutions against a 
(0.03%) was added to the solvent in order to protect the 
acterial growth during the long osmometric experiment. 
T 
p/" 
hydrostatic pressure method (static osmometer) was applied (11) and a 
eriod of 48 hours was required to obtain equiLibrium. No correction for the 
Donnan effect (as is the case with light scattering) is needed for an 
osmometry experiment (10). Concentration-dependent z values were derived for 
each concentration from the equilibrium osmotic npressure. Straight line 
extrapolation of l/i? to zero concentration was possible, 
with a lo-15% repr"ducibil.ity. A much worse 
yielding the true R 
reproducibility was found: 
however, for the determination (from the same plots) of second virial 
coefficients. Values ranging from 0.001 to 0.008 mol.ml/g (not systematically 
varying with En> were found - this kind of measurement usually has no good 
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reproducibility (11). In all cases, however, significantly positive slopes 
were found. Hence, our solvent is certainly not a theta-solvent (as is, for 
instance, water containing 0.5 M NaCl for heparin from another origin (2)). 
Viscometry: Viscosity measurements were performed at 25 & 0.002 OC using an 
Ubbelohde viscometer (11). Flow times were determined in trinlicate for at 
least 3 dilutions (for solvent and highest concentration see osmometry, above) 
and did not differ more than 0.2 seconds for each concentration. Intrinsic 
viscosities [q] were calculated by plotting qsp /c and (In qr )/c against c, 
and taking the mean of the intercepts thus obtained (11). The experimental 
error in each intrinsic viscosity value was jI 0.2 ml/g. 
Our Mark-Houwink relation (equation (1) below) was calculated by means of an 
iterative procedure in order to obtain K and a values independent of 
polydispersity. First, w 
fractional distribution usyng 
(equation (2) below) was estimated for each 
of lo&] against 1ogE . Then, 
preliminary K and a values derived from a plot 
the log[z] 
obtained, and new K" and a were 
were plotted against the loggv thus 
calculated from intercept and slope, 
respectively. These new values were used for the recalculation of new 3 
values, that were plotted again. After three iterations, K and a were constane 
and a straight line with regression coefficient 0.97 for the 8 data-points was 
obtained. 
Ultracentrifugation: The B and B derived with the HPLC-LALLS method were 
checked, for the unfracti:nated tiosynth sample and for fraction 83, by 
equilibrium ultracentrifugation (in a Beckmann Spinco model E). Cl& 
experimental procedure was the same as that of Barlow (2), who processed the 
experimental data according to a computer program used in ScholteFs "variable 
rotor speed" procedure (12). We could not use this program, however, our 
solvent being not a theta-solvent. Therefore, we performed our measurements at 
more than one concentration (see above for the concentration range) and 
calculated molecular mass averages according to another procedure outlined by 
Scholte (13) for the variable rotor speed method. The reciprocal values of the 
molecular masses were extrapolated to zero concentration, and again 
significantly positive second virial coefficients were found in the range as 
mentioned above for the osmometric measurements. The reproducibility of the 
true molecular masses thus obtained is comparable to that of osmometry: 
lo-15%. 
Again, a dialysis procedure as described above for the HPLC-LALLS method 
prevented the occurrence of Donnan-type artefacts in the results. In this 
case, not only refractivity index increments were measured against the 
dialysis equilibrium liquid as the blank, but also the buoyancy factors (1 - 
cd) (10). For the partial volume '5 we found 0.43 ml/g for Diosynth and 0.50 
for fraction #3, in accordance with earlier measurements by other workers 
(2,3). These data were calculated from density measurements in a PAAR Digital 
Density Meter (DMA 50, Anton Paar K.G., Graz). 
RESULTS 
HPLC-LALLS measurements: Two series of HPLC measurements were carried out. The 
first for characterization of henarin standards with the LALLS as a detector, 
the second for studying the -transferability of the standard data for 
calibration. For the first (characterization) series of measurements we used 
two columns in series (PW 3000 and 4000 , specifications given above), 
connected to the LALLS and to the refractometer, for the second (calibration) 
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series the LALLS was disconnected and only one column (the SW 3000) was used. 
This column has a higher resolution than the two PW columns in series because 
it is linear over the range of expected molecular masses, and therefore it 
should be preferred for calibration purposes over the PW columns. The SW 3000 
column, however, released small particles during the experiments, which 
renders it unreliable for use with the subtle LALLS detecting system (too much 
noise on the LALLS recorder signal). 
A microcomputer processed the detector signals and calculated the molecular 
mass distributions and the mean molecular masses. For the characterization of 
samples by means of the LALLS system, correction for the second virial 
coefficient was necessary and performed as indicated by Ouano (14). The second 
virial coefficient (determined by osmometry and confirmed by 
ultracentrifugation, see above) was assumed to be 0.0045 mol.ml/g for the 
whole range of molecular masses. The bad reproducibility of the second virial 
coefficient determination causes an uncertainty of 15% in the molecular 
masses, determined by the HPLC-LALLS method, presented in Table 1. 
Correction parameters for column dispersion were calculated directly from the 
HPLC-LALLS measurements by a procedure outlined by Zhi-Duang He e.a. (15)) and 
were found to be very small for the two column system. For the SW 3000 column 
the same had been found earlier by Leypoldt e.a. (16). According to these 
workers, the a and R calculated with and without such small dispersion 
correction parageters I&-dly differ. Hence, we omitted these parameters from 
our calculations, the more so, because the errors in the molecular masses are 
determined almost exclusively by the experimental uncertainty in the second 
virial coefficient. Molecular mass distributions calculated from our 
HPLC-LALLS measurements in the same way as the average molecular masses are 
shown in fig. 1 (next page). 
TABLE 1 -- 
Molecular Mass Averages (in g/mol) from HPLC-LALLS Measurements 
HPLC-LALLS (HL) compared to some results of measurements with osmometer (OS) 
and ultracentrifuge (UC). Ve is the elution volume belonging to the top of the 
distribution curve. 
Sample 
(Name or # of 'e 
fraction) ml 
Kabi 23.25 6200 6700 7400 9300 
6 22.60 6700 8800 8200 10600 
5 22.05 10500 11200 11800 13300 
4 21.80 9800 12500 12000 14900 
3 21.40 11700 13900 15500 13000 18900 25000 
Diosynth 21.50 12300 12000 17700 18000 22500 30000 
2 20.85 16500 20500 20800 24300 
1 20.00 22200 30300 38900 
HL OS HL UC HL UC 
Table 1 also compares the HPLC-LALLS results with those of osmometry and 
ultracentrifugation. Within the experimental errors inherent to each method 
(see above), the results are reasonably well in agreement. This means that 
light scattering (and, therefore, HPLC-LALLS) is a valid method for the 
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determination of molecular masses of heparin - provided that its 
polyelectrolyte behavior is properly corrected for by the dialysis procedure 
described above. 
molecular weight x 10q3 
FIG.1 Molecular mass distribution (mass fraction frequency) of 
heparin samples. Not corrected for column spreading (see text). 
(0) Diosynth, (IJ) fraction 81, (a) fraction %6. 
Still one remark has to be made concerning Table 1. Usually, top-of-peak 
elution volumes decrease with increasing average molecular mass. This, 
however, does not seem to be the case for the unfractionated Diosynth sample. 
The solution to this paradox is, that top-of-peak elution volumes for 
polydisperse samples (with broad and skewed elution peaks ,like the Diosynth 
sample) not necessarily coincide with the calibration curve (17). For this 
curve the log % of low polydispersity samples (with "M /w < 1.3, say, and 
with a narrow &kewed elution peak, like the fraction2 @l-l/6) are plotted 
against the corresponding top-of-peak elution volumes. 
Mark-Houwink relation: Table 2 shows that calculation of molecular mass 
averages according to the Mark-Houwink equation proposed by Lasker and Stivala 
(3) leads to results that are very different from all the results of Table 1. 
In the Discussion Section it is explained that this has to do with the other 
origin of the samples studied by these workers, and not with the fact that 
Lasker and Stivala (3) used an aqueous salt-solution (0.1 M NaCl) different 
from ours (0.1 M Na-acetate). For our heparin samples we obtained the 
Mark-Houwink relation: 
(1) [$ = K.MVa , with: K = (6.97 f 0.20)*10-4 (ml/g) , and 
a = 1.03 r 0.02 
The "M of the fourth column of Table 2 are derived from the R as given in the 
last Zolumn. Hence, the rather large experimental uncertaintss in K and a of 
equation (1) are consequences of the experimental uncertainty in the osmotic 
second virial coefficient correction used in the calculation of molecular 
masses from the LALLS signals, and of the reproducibility of the LALLS 
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signals. The 'i calculated according to equation (1) when the experimental 
uncertainties ix K and a are taken into account, however, differ significantly 
from those derived from Lasker and Stivala's Mark-Houwink relation (3) (third 
column of Table 2). 
TABLE 2 -- 
Mass- and Viscosity -average Molecular Masses 
Molecular masses calculated from Mark-Houwink relations, as determined by 
Lasker and Stivala (LS) (3) and by us (equation (l)), and compared to the 
HPLC-LALLS results (HL). 
Sample 
(Name or i/ of " 
" 
B 
W 
fraction) ml/g LS (1) HL 
Kabi 5.7 3842 6233 7400 
6 8.7 5914 9393 8200 
5 10.9 7444 11688 11800 
4 12.9 8841 13763 12000 
3 14.9 10241 15828 15500 
Diosynth 16.9 11646 17884 17700 
2 18.9 13054 19934 20800 
1 29.1 20277 30295 30300 
As a is close to 1, 'i is close to R 
V w (wi in (2) is the mass fraction of species i) : 
(2) Ev = (~w~M~~)“~ c r wiMi = SW 
Thus, M 's may be calculated directly from our Mark-Houwink relation. Its 
applicafion to heparin samples of another origin than ours is not directly 
possible, however. 
HPLC calibration: As was stated by the inter-laboratory survey report 
mentioned above (6), the degree of the polynomial describing a HPLC 
calibration curve based on standard heparins should be of great importance 
(this is supported by the model calculations on HPLC data treatment by Ogawa 
and Inaba (17)). Hence, two calibration curves for the second series of HPLC 
measurements (SW 3000 column, no LALLS) were derived from the first series of 
measurements, a cubic one and a linear one, 
The calibration procedure for the SW column was as follows. The eight heparin 
samples were injected on the SW 3000 column. For each sample, at elution 
volumes V. separated from each other by 0.5 ml, 
having alretention volume > V. 
the weight fraction of heparin 
weight fractions, in turn, wer!e 
was determined from the chromatogram. The 
correlated to molecular masses using the 
cumulative mass distributions obtained from the HPLC-LALLS calibration 
measurements. Due to overlap of the different fractions, 1 to 3 molecular 
weights were obtained per elution volume. Then least squares cubic and linear 
fits were calculated through the elution volumes (as the independent 
variables) and the natural logarithms of the corresponding molecular masses 
(as the dependent variables). 
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From the calibration curves, molecular mass distributions were calculated by a 
procedure outlined by Yau et al. (18). As a check to the reliability of this 
procedure for the transfer of calibration data obtained on the two PW column 
set to the one SW column, it was also applied to the calculation of cubic and 
linear calibration curves for the two-column calibrating system itself (TSK PW 
3000 and 4000), from which the molecular mass distributions of the calibrating 
samples were recalculated. 
The results are presented in Tables 3 - 5. The cubic calibration curve 
(columns "Cal 1") for the two column set certainly covers the whole range of 
original (i.e. HPLC-LALLS) molecular mass averages best, generally speaking, 
and apart from the results for the Kabi and Diosynth samples (an explanation 
is given below). 
The molecular masses as determined by HPLC-LALLS of the Kabi and Diosynth 
samples are not very well reproduced by the calibration curve calculation, 
neither with the cubic curve based on all the samples (including the outliers 
Kabi and Diosynth), nor with the straight line based on the 3 narrow-peak 
samples. In our opinion, this has to do with an experimental error inherent to 
the HPLC-LALLS method. At the high molecular mass tail (low elution volume) 
the LALLS signal is reasonably high while the dn/dc signal is low, whereas the 
reverse is true for the high elution volume tail. The - ambiguous (17) - 
choice of the positioning of the baselines of the two recorder signals, 
therefore, especially biases the calculation of the molecular mass 
distributions of the Kabi and Diosynth samples. The Kabi sample has a very 
small LALLS signal, whereas the elution peak of the Diosynth sample is 
extended from the lowest to the highest elution volumes (cf. figure 1). 
TABLE 3 _- 
Number average Molecular Masses from calibrated HPLC Measurements 
The results are compared to the same averages calculated from 
HPLC-LALLS measurements (HL). Explanation of column headings: 
cal 1 : two column system, cubic calibration curve based on fractional 
distribution (see text). cal 2 : same, linear calibration . 
cal 3 : one column system, cubic calibration curve based on fractional 
distribution. cal 4 : same, linear calibration. 
cal 5 : one column system, linear calibration with 3 widely different 
narrow distribution samples only (see the Discussion Section). 
Sample 
(Name or # of 
fraction) 
Mn 'n 
?z 
n 'n % 'n 
cal 1 cal 2 cal 3 cal 4 cal 5 HL 
Kabi 5000 5300 5300 4900 5900 6200 
6 4600 7600 6900 6700 7600 6700 
5 8800 9000 9000 8800 9800 10500 
4 11000 10700 11000 10900 11800 9800 
3 14000 13900 14000 14000 14800 11700 
Diosynth 11400 11400 11600 11100 12400 12300 
2 18800 19700 18900 19300 19900 16500 
1 27900 26200 28700 27900 29700 22300 
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TABLE 4 -- 
Mass average Molecular Masses from calibrated HPLC Measurements 
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For column headings cf. Table 3. 
Sample 
(Name or # of 
fraction) 
Mw gw x” R E W W SW 
cal 1 cal 2 cal 3 cal 4 cal 5 HL 
6000 6600 6200 5700 6800 7400 
8600 8900 8700 8600 9300 8200 
11200 11100 11200 11000 11900 11800 
13200 12900 13200 12900 14000 12000 
15900 16100 15900 15800 16800 15500 
15700 15000 15900 15000 16700 17700 
21300 21500 21700 21100 22600 20800 
32800 28300 34600 31400 35300 30300 
Kabi 
6 
5 
4 
3 
Diosynth 
2 
TABLE 5 -- 
Z-average Molecular Masses from calibrated HPLC Measurements 
For column headings cf. Table 3. 
Sample 
(Name/# of 
fraction) cal 1 cal 2 cal 3 cal 4 cal 5 HL 
Kabi 7400 7100 7400 6900 8000 9300 
6 11100 11100 11100 11000 11700 10600 
5 13700 13700 13700 13400 14400 13300 
4 15700 15500 15800 15100 16600 14900 
3 18000 18200 18200 17500 19000 18900 
Diosynth 21100 18900 22000 19100 22500 22500 
2 24200 23100 25100 23000 25800 24300 
1 38100 29300 41400 34000 41700 38900 
Universal calibration: Figure 2 (next page) presents the results of the 
universal calibration procedure (8). The calibration curve is a plot of the 
(logarithm of the) hydrodynamic volumes, p ) of different polymers in the 
same solvent against the corresponding (top-)elution volumes (the hydrodynamic 
volume p is represented by the product of intrinsic viscosity and molecular 
mass: I* = [q].Gv>. 
In figure 2 the p-values (determined from measurements in the same solvent as 
that used for our heparin samples) for three dextrane fractions and four 
polyethylene glycol fractions are plotted. Within experimental error, these 
can be described by one and the same curve. 
Surprisingly, however, the )4-values of our heparin samples are not covered by 
this curve and heparin molecular masses derived from this curve are greatly 
overestimated in the low molecular mass region. Maybe this has to do with the 
fact that heparin molecules are not randomly coiled (as indicated by the value 
of the Mark-Houwink exponent a > 0.8), while dextrane and polyethylene glycol 
472 STANDARDIZATION OF HEPARINS 
are. This explanation has been given by Lambert e.a. (19) for the deviation 
from the universal calibration curve they found for the xanthan gum. This 
deviation is precisely the reason why these workers advocate the use of LALLS 
as a HPLC detector for their polymer. 
I , I , 
I9 20 21 22 23 
I 
24 
Ve 
PIG.2 Universal calibration in aqueous 0.1 M NaAc solution adjusted to pH 
6.0: logarithm of hydrodynamic volume (see text) plotted against top-of-peak 
elution volume. Upper points: polyethyleneglycol and dextrane. Lower points: 
heparin fractions. 
DISCUSSION 
The problem of the determination of average molecular masses of heparin, so 
important for establishing relations between molecular mass and biological 
activity (9), is solved in principle when one can calibrate relations like 
that of Mark-Houwink and HPLC calibration curves by well-characterized heparin 
samples of the same origin. As we have shown, HPLC-LALLS (gel permeation 
chromatography coupled to a light scattering detector) characterizes such 
samples conveniently and reliably (i.e. comparison with osmometry and 
equlibrium ultracentrifugation does not reveal any systematic error). 
An objection to light scattering as a method could be that heparin, in a 
sense, is a random copolymer (1). It is well-known that random copolymers are 
very difficult to characterize by light scattering of solutions (20). Unless 
at least three different solvents are used, apparent molecular masses are 
derived allways from the measurements, sometimes far too high. This does not 
seem to be the case for our series of heparins: the molecular masses are 
reasonably well in agreement with those determined by osmometry and 
ultracentifugation. Thus, we infer that heparins from the same origin are 
rather constant in chemical composition (i.e. with respect to sequence length 
and sequence composition along the chain backbones). 
Moreover, a straight line Mark-Houwink relationship between loglq] and logz 
has been obtained for our samples. This would not have been so when they ha8 
consisted of molecules greatly differring in sequence distribution. Thorough 
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chemical analysis of several heparins has revealed (1) that differences in 
sequence lengths and compositions do occur, but that they are much greater 
between molecules of heparins from different origin than between heparin 
molecules belonging to samples from the same origin . Hence, the latter are 
more like proteins: those are also random copolymers, but of such constancy in 
chemical composition that no problems arise in the interpretation of light 
scattering measurements and true molecular masses can allways be derived (20). 
Our finding that dnfdc seems to increase with molecular mass (see above) does 
not contradict this conclusion about the constant chemical composition of the 
heparin molecules of our samples. Such a (small) molecular mass effect is not 
uncommon for the molecular mass range we studied (21). 
The exponent a of equation (1) is within experimental error equal to that 
found by Lasker and Stivala (3) and by Liberti and Stivala (4), namely 0.98 
and 1.00, respectively, for fractions of beef-lung heparin in aqueous 
solutions of an ionic strength equa13to that of _"yr solutions. Their K, 
however, are very different: 1.75*10 and 1.54*10 (ml/g), respectively. 
This difference in K should be attributed to differences in sequence 
distribution between heparins of different origin. The exponent a stems from 
the long range interactions: those between the polymer molecules and those 
between them and the salt-ions and the solvent molecules (22). In contrast, K 
is a complicated function (22) not only of these long range interactions but 
also of the short range interactions (determined by the mutual positioning of 
adjacent monomeric units, different for heparins of differing origin). Thus, 
heparins from different origins but dissolved in the same solvent (see next 
paragraph) should have similar values for the exponent a and different values 
for the coefficient K. 
Aqueous solutions of l-l salts (like NaCl and Na-acetate) are considered by us 
as the same solvent, provided that (i) the ionic strengths are equal, and (ii) 
the positively charged ions are the same. We are justified to do so because 
the oppositely charged (i.e. positively) small ions, and not the co-ions, 
determine the net charge of the negatively charged heparin molecules and thus 
the short range and the long range interactions. We would not consider aqueous 
solutions of AgN03 and NaCl to be the same solvents, however, even if their 
ionic strengts were equal, because silver-ions may exhibit "site-binding" to 
charged groups on heparin molecules whereas sodium-ions do not (10). 
The universal calibration method does not seem to work for aqueous solutions 
of dextrans, polyethyleneglycols and heparins. (Maybe it does within the class 
of heparins as such, regardless of their origin - this will be the subject of 
coming work). We also tried to derive heparin molecular masses from the 
non-universal calibration curves (i.e. 1ogR plotted directly against 
top-of-peak elution volume) of dextrane or polyethylene glycol in the same 
solvent as that used for heparin. The results were not presented above, as 
they add nothing new to our conclusion from figure 2: the non-universal 
calibration curve also overestimates the molecular masses of the heparin 
samples, but now over the whole molecular mass range. Thus, we have confirmed 
the familiar conclusion that heparins should be calibrated with heparins and 
that heparin molecular masses should never be determined from HPLC 
measurements calibrated by other polymers than heparin. Our conclusion reaches 
further, however: one should calibrate heparins with heparins from the same 
origin. 
The transfer of the HPLC-LALLS results to the other column does not lead to 
appreciable deviations from the original '"in, r";iw and fla values, as Tables 3-5 
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show. These are reasonably well reproduced for the whole range of molecular 
masses, even if a linear calibration line (columns "Cal 2" and "Cal 4") is 
applied. Cubic calibration curves (columns "Cal 1" and "Cal 3" in Tables 3 - 
6) seem to be superior in covering the whole range of molecular masses, 
however, in accordance with the findings of other authors (8), (17). 
Surprisingly, even a linear calibration line based on only 3 narrow-peak 
samples gives acceptable results: see the column "calibration # 5" in Tables 3 
- 5. The top-of-peak elution volumes and molecular masses used for the 
calculation of this line were those belonging to the elution peaks of 3 narrow 
distribution samples of widely differing mean molecular masses, though 
equidistantly spread over the log@ ) range (fractions #6, #4 and /i2). This 
has an obvious advantage: only 3 %ell-characterized samples and a linear 
calibration line are needed for the calibration of a (set of) column(s) when 
not the utmost accuracy is required. 
The determination of complete molecular mass distributions, if desired, is 
also possible by means of properly calibrated HPLC. For the determination of 
such distributions, however, one should not omit (as we did) the column 
dispersion correction: a small correction has almost no influence on the 
average molecular masses, but it can influence greatly the shape of the 
distribution at the low and high molecular mass tails (16). 
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